Bioactive Materials (Jul 2023)

Apoptotic vesicles ameliorate lupus and arthritis via phosphatidylserine-mediated modulation of T cell receptor signaling

  • Runci Wang,
  • Meng Hao,
  • Xiaoxing Kou,
  • Bingdong Sui,
  • Maria Laura Sanmillan,
  • Xiao Zhang,
  • Dawei Liu,
  • Jun Tian,
  • Wenjing Yu,
  • Chider Chen,
  • Ruili Yang,
  • Lingyun Sun,
  • Yi Liu,
  • Claudio Giraudo,
  • Deepak A. Rao,
  • Nan Shen,
  • Songtao Shi

Journal volume & issue
Vol. 25
pp. 472 – 484

Abstract

Read online

Mesenchymal stem cells (MSCs) influence T cells in health, disease and therapy through messengers of intercellular communication including extracellular vesicles (EVs). Apoptosis is a mode of cell death that tends to promote immune tolerance, and a large number of apoptotic vesicles (apoVs) are generated from MSCs during apoptosis. In an effort to characterize these apoVs and explore their immunomodulatory potential, here we show that after replenishing them systemically, the apoV deficiency in Fas mutant mice and pathological lymphoproliferation were rescued, leading to the amelioration of inflammation and lupus activity. ApoVs directly interacted with CD4+ T cells and inhibited CD25 expression and IL-2 production in a dose-dependent manner. A broad range of Th1/2/17 subsets and cytokines including IFNγ, IL17A and IL-10 were suppressed while Foxp3+ cells were maintained. Mechanistically, exposed phosphatidylserine (PtdSer/PS) on apoVs mediated the interaction with T cells to disrupt proximal T cell receptor signaling transduction. Remarkably, administration of apoVs prevented Th17 differentiation and memory formation, and ameliorated inflammation and joint erosion in murine arthritis. Collectively, our findings unveil a previously unrecognized crosstalk between MSC apoVs and CD4+ T cells and suggest a promising therapeutic use of apoVs for autoimmune diseases.

Keywords